410 related articles for article (PubMed ID: 11380224)
1. Conformal re-irradiation of recurrent and new primary head-and-neck cancer.
Dawson LA; Myers LL; Bradford CR; Chepeha DB; Hogikyan ND; Teknos TN; Terrell JE; Wolf GT; Eisbruch A
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):377-85. PubMed ID: 11380224
[TBL] [Abstract][Full Text] [Related]
2. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
3. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer.
Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH
Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456
[TBL] [Abstract][Full Text] [Related]
4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
5. Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients.
De Crevoisier R; Bourhis J; Domenge C; Wibault P; Koscielny S; Lusinchi A; Mamelle G; Janot F; Julieron M; Leridant AM; Marandas P; Armand JP; Schwaab G; Luboinski B; Eschwege F
J Clin Oncol; 1998 Nov; 16(11):3556-62. PubMed ID: 9817275
[TBL] [Abstract][Full Text] [Related]
6. Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease.
Haraf DJ; Weichselbaum RR; Vokes EE
Ann Oncol; 1996 Nov; 7(9):913-8. PubMed ID: 9006741
[TBL] [Abstract][Full Text] [Related]
7. Salvage re-irradiation for recurrent head and neck cancer.
Lee N; Chan K; Bekelman JE; Zhung J; Mechalakos J; Narayana A; Wolden S; Venkatraman ES; Pfister D; Kraus D; Shah J; Zelefsky MJ
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):731-40. PubMed ID: 17379449
[TBL] [Abstract][Full Text] [Related]
8. Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: long-term results.
Puthawala A; Nisar Syed AM; Gamie S; Chen YJ; Londrc A; Nixon V
Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):354-62. PubMed ID: 11567809
[TBL] [Abstract][Full Text] [Related]
9. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer.
Dawson LA; Anzai Y; Marsh L; Martel MK; Paulino A; Ship JA; Eisbruch A
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1117-26. PubMed ID: 10725621
[TBL] [Abstract][Full Text] [Related]
10. Re-irradiation of head and neck cancer-impact of total dose on outcome.
Janssen S; Baumgartner M; Bremer M; Warszawski A; Stieve M; Eckardt A; Karstens JH; Meyer A
Anticancer Res; 2010 Sep; 30(9):3781-6. PubMed ID: 20944169
[TBL] [Abstract][Full Text] [Related]
11. Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer: a prospective phase I/II trial.
Hehr T; Classen J; Belka C; Welz S; Schäfer J; Koitschev A; Bamberg M; Budach W
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1423-31. PubMed ID: 15817346
[TBL] [Abstract][Full Text] [Related]
12. Concurrent chemoradiotherapy with low-dose cisplatin plus 5-fluorouracil for the treatment of patients with unresectable head and neck cancer.
Kohno N; Kitahara S; Tamura E; Tanabe T
Oncology; 2002; 63(3):226-31. PubMed ID: 12381901
[TBL] [Abstract][Full Text] [Related]
13. Re-irradiation Using Intensity-modulated Radiotherapy for Recurrent and Second Primary Head and Neck Cancer.
Choi SH; Chang JS; Choi J; Park SH; Keum KC; Park KR; Lee CG
Anticancer Res; 2018 May; 38(5):3165-3173. PubMed ID: 29715158
[TBL] [Abstract][Full Text] [Related]
14. Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.
Wanebo HJ; Glicksman AS; Landman C; Slotman G; Doolittle C; Clark J; Koness RJ
Am J Surg; 1995 Nov; 170(5):512-6. PubMed ID: 7485745
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of HPV status in the re-irradiation of recurrent and second primary cancers of the head and neck.
Velez MA; Wang PC; Hsu S; Chin R; Beron P; Abemayor E; St John M; Chen AM
Am J Otolaryngol; 2018; 39(3):257-260. PubMed ID: 29433815
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.
Biagioli MC; Harvey M; Roman E; Raez LE; Wolfson AH; Mutyala S; Han HS; Markoe A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1067-73. PubMed ID: 17967302
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo Clinic.
Curtis KK; Ross HJ; Garrett AL; Jizba TA; Patel AB; Patel SH; Wong WW; Halyard MY; Ko SJ; Kosiorek HE; Foote RL
Radiat Oncol; 2016 Apr; 11():55. PubMed ID: 27061083
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated radiotherapy for previously irradiated, recurrent head-and-neck cancer.
Chen YJ; Kuo JV; Ramsinghani NS; Al-Ghazi MS
Med Dosim; 2002; 27(2):171-6. PubMed ID: 12074469
[TBL] [Abstract][Full Text] [Related]
19. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation.
Lee N; Xia P; Fischbein NJ; Akazawa P; Akazawa C; Quivey JM
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):49-60. PubMed ID: 12909215
[TBL] [Abstract][Full Text] [Related]
20. Chemo-reirradiation in persistent/recurrent head and neck cancers.
Nagar YS; Singh S; Datta NR
Jpn J Clin Oncol; 2004 Feb; 34(2):61-8. PubMed ID: 15067097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]